HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Doxorubicin bound to a HPMA copolymer carrier through hydrazone bond is effective also in a cancer cell line with a limited content of lysosomes.

Abstract
We have synthesized conjugates containing doxorubicin (DOX) bound to oligopeptide side chains (GlyGly or GlyPheLeuGly) of a water-soluble copolymer carrier based on poly[N-(2-hydroxypropyl)methacrylamide] (PHPMA) either through proteolytically (PK1 conjugates) [Synthetic polymeric drugs. U.S. Patent 5,037,883 (1991)] or hydrolytically cleavable bond (HC conjugates). Pharmacological efficacy of PK1 and HC conjugates was compared in vitro on murine: T-cell lymphoma EL4, B-cell leukemia BCL1, B-cell lymphoma 38C13, leukemia P388 and Con A-stimulated A/Ph splenocytes and on human: primary (SW480) and metastatic (SW620) colorectal cancer cell lines parent and transfected with Thy 1.2 gene [2] and on erythromyeloid leukemia cell line K 562. Inhibition of proliferation determined by 3[H]-thymidine incorporation revealed that the cytostatic effect of HC conjugates is up to two orders of magnitude higher compared to PK1 conjugates. In some cancer cell lines (SW 620/T, SW 480) the pharmacological activity of HC conjugates is in vitro comparable with the activity of the free drug. Unlike PK1 conjugates, HC conjugates with a lysosomally degradable spacer (GlyPheLeuGly) are less effective compared to HC conjugates containing lysosomally non-degradable spacer (GlyGly). Moreover, HC conjugates exert pronounced anti-proliferative activity also in erythroblastoid leukemia cell line K 562 with a limited content of lysosomes.
AuthorsB Ríhová, T Etrych, M Pechar, M Jelínková, M Stastný, O Hovorka, M Kovár, K Ulbrich
JournalJournal of controlled release : official journal of the Controlled Release Society (J Control Release) Vol. 74 Issue 1-3 Pg. 225-32 (Jul 06 2001) ISSN: 0168-3659 [Print] Netherlands
PMID11489498 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibiotics, Antineoplastic
  • Drug Carriers
  • Hydrazones
  • Methacrylates
  • Oligopeptides
  • Polymethacrylic Acids
  • Duxon
  • Doxorubicin
  • hydroxypropyl methacrylate
Topics
  • Animals
  • Antibiotics, Antineoplastic (administration & dosage, chemistry)
  • Doxorubicin (administration & dosage, chemistry)
  • Drug Carriers
  • Hydrazones (chemistry)
  • Lysosomes (chemistry)
  • Methacrylates
  • Mice
  • Molecular Weight
  • Neoplasms (drug therapy)
  • Oligopeptides (administration & dosage, chemistry)
  • Polymethacrylic Acids
  • Spleen (cytology, drug effects)
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: